CASSAVA SCIENCES INC. - COMMON STOCK
26.48
22-11月-24 16:44:58
15 分の遅延
株式
-5.70
-17.71%
本日の幅
26.02 - 31.40
ISIN
N/A
ソース
NASDAQ
-
Webcast Details for Cassava Sciences’ Upcoming Fireside Chat
04 4 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Fireside Chat and Presentation Tuesday, April 5th
30 3 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
28 2 2022 16:03:00 提供 Nasdaq GlobeNewswire
-
FDA Denies Citizen Petitions Filed on Behalf of Short Selling Clients
10 2 2022 16:07:38 提供 Nasdaq GlobeNewswire
-
23 12 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication
21 12 2021 09:30:00 提供 Nasdaq GlobeNewswire
-
18 11 2021 09:15:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Third Quarter 2021 Financial Results
10 11 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
04 11 2021 09:30:00 提供 Nasdaq GlobeNewswire
-
06 10 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
22 9 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
09 9 2021 08:15:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Releases a Public Statement Regarding Recent Allegations
03 9 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
27 8 2021 11:31:59 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Responds to Allegations
25 8 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
24 8 2021 08:15:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Second Quarter 2021 Financial Results
03 8 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Conference Call for Second Quarter Financial Results
02 8 2021 19:54:18 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease
29 7 2021 09:53:35 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
29 7 2021 09:53:30 提供 Nasdaq GlobeNewswire